Incyte Logo

Incyte

🇺🇸
INCY
US45337C1027

Incyte, a US-based biopharmaceutical company, is dedicated to the discovery, development, and commercialization of innovative therapeutics. With a strong focus on oncology, inflammation, and autoimmune diseases, Incyte aims to improve the lives of patients globally. The company drives medical progress through targeted research and development, striving to provide much-needed treatment solutions.

Next Quarterly Earnings

Tuesday, August 4, 2026
CW 32
Pre-Market
In 30 days

Stock Price

All Dates

Company Information

Name
Incyte
Ticker Symbol
INCY
ISIN
US45337C1027
Country
🇺🇸
USA
More Financial Information